{"transactions":[{"id":754216,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:21:14.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001502785-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000150278526000001/primarydocument.xml","form_type":"4"}},{"id":754215,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:21:14.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the recipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001502785-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000150278526000001/primarydocument.xml","form_type":"4"}},{"id":989719,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T00:05:05.000Z","date":"2025-11-21","kind":"grant","planned":false,"acquired":true,"shares":964000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":964000,"derivative":{"exercise_price":2.9,"expiration_date":"2035-11-21","underlying":"Ordinary Shares","underlying_shares":964000},"source":{"system":"sec-edgar","filing":"0001502785-25-000004","document":"form4-11242025_071101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000150278525000004/form4-11242025_071101.xml","form_type":"4"}},{"id":1124382,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:33:32.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004353","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218025004353/primarydocument.xml","form_type":"4"}},{"id":1124381,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:33:32.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004353","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218025004353/primarydocument.xml","form_type":"4"}},{"id":1341387,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-05T21:15:08.000Z","date":"2024-12-04","kind":"grant","planned":false,"acquired":true,"shares":813200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0511 to EURO 1.00 as of December 4, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in four equal annual installments commencing on December 4, 2025, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":813200,"derivative":{"exercise_price":0.89,"expiration_date":"2034-12-04","underlying":"Ordinary Shares","underlying_shares":813200},"source":{"system":"sec-edgar","filing":"0001415889-24-028393","document":"form4-12052024_041202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000141588924028393/form4-12052024_041202.xml","form_type":"4"}},{"id":1491588,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-04T20:40:24.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":24454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer."}],"balance_after":24454,"derivative":{"exercise_price":14.35,"expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":24454},"source":{"system":"sec-edgar","filing":"0001562180-24-004650","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218024004650/primarydocument.xml","form_type":"4"}},{"id":1491587,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:40:24.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-004650","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218024004650/primarydocument.xml","form_type":"4"}},{"id":1583717,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Ordinary Shares","published_at":"2024-03-11T20:15:38.000Z","date":"2024-03-08","kind":"purchase","planned":false,"acquired":true,"shares":17094,"price":0.83,"value":14188.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"), each of which currently represents one-half of one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represent the ADS price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8123 to $0.8612 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17094,"source":{"system":"sec-edgar","filing":"0001415889-24-007503","document":"form4-03112024_040312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000141588924007503/form4-03112024_040312.xml","form_type":"4"}},{"id":1730839,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-22T12:04:17.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":806672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0928 to EURO 1.00 as of November 20, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in four equal annual installments commencing on November 20, 2024, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":806672,"derivative":{"exercise_price":2.19,"expiration_date":"2033-11-20","underlying":"Ordinary Shares","underlying_shares":806672},"source":{"system":"sec-edgar","filing":"0001209191-23-056409","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000120919123056409/doc4.xml","form_type":"4"}},{"id":1808286,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-14T20:32:50.000Z","date":"2022-11-21","kind":"grant","planned":false,"acquired":true,"shares":764386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0242 to EURO 1.00 as of November 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":764386,"derivative":{"exercise_price":3.07,"expiration_date":"2032-11-21","underlying":"Ordinary Shares","underlying_shares":764386},"source":{"system":"sec-edgar","filing":"0001209191-23-045642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000120919123045642/doc4.xml","form_type":"4"}},{"id":1864909,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-06T21:13:03.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":17892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer."}],"balance_after":17892,"derivative":{"exercise_price":19.72,"expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":17892},"source":{"system":"sec-edgar","filing":"0001562180-23-004894","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218023004894/primarydocument.xml","form_type":"4"}},{"id":1864908,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:13:03.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":3486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer."}],"balance_after":6496,"source":{"system":"sec-edgar","filing":"0001562180-23-004894","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218023004894/primarydocument.xml","form_type":"4"}},{"id":2239965,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T20:23:27.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer."}],"balance_after":15324,"derivative":{"exercise_price":22.84,"expiration_date":"2032-06-03","underlying":"Common Stock","underlying_shares":15324},"source":{"system":"sec-edgar","filing":"0001562180-22-004881","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218022004881/primarydocument.xml","form_type":"4"}},{"id":2239964,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:23:27.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":3010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer."}],"balance_after":3010,"source":{"system":"sec-edgar","filing":"0001562180-22-004881","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218022004881/primarydocument.xml","form_type":"4"}},{"id":2494836,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-24T21:15:03.000Z","date":"2021-11-22","kind":"grant","acquired":true,"shares":274000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.1278 to EURO 1.00 as of November 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on November 22, 2022, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share."}],"balance_after":274000,"derivative":{"exercise_price":6.62,"expiration_date":"2031-11-22","underlying":"Ordinary Shares","underlying_shares":274000},"source":{"system":"sec-edgar","filing":"0001209191-21-066789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000120919121066789/doc4.xml","form_type":"4"}},{"id":2677099,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T20:22:38.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following June 4, 2021."}],"balance_after":10000,"derivative":{"exercise_price":35.52,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-21-004131","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218021004131/primarydocument.xml","form_type":"4"}},{"id":3126534,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T20:37:15.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 29, 2020."}],"balance_after":10000,"derivative":{"exercise_price":37.66,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-20-004071","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218020004071/primarydocument.xml","form_type":"4"}},{"id":3501773,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T20:24:21.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 31, 2019."}],"balance_after":10000,"derivative":{"exercise_price":43.02,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-19-003297","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218019003297/primarydocument.xml","form_type":"4"}},{"id":3883836,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-25T20:33:08.000Z","date":"2018-06-21","kind":"grant","acquired":true,"shares":11987,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":182604,"source":{"system":"sec-edgar","filing":"0001600132-18-000100","document":"wf-form4_152995877123610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000160013218000100/wf-form4_152995877123610.xml","form_type":"4"}},{"id":3901269,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-07T20:53:28.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":38216,"price":2.27,"value":86750.32,"ownership":{"direct":true},"balance_after":58216,"derivative":{"exercise_price":2.27,"exercise_date":"2019-06-05","expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":38216},"source":{"system":"sec-edgar","filing":"0001600132-18-000072","document":"wf-form4_152840478940399.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000160013218000072/wf-form4_152840478940399.xml","form_type":"4"}},{"id":3913781,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-30T20:35:54.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 25, 2018."}],"balance_after":12500,"derivative":{"exercise_price":49.45,"expiration_date":"2028-05-25","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-18-002719","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000156218018002719/primarydocument.xml","form_type":"4"}},{"id":4201424,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-26T20:59:12.000Z","date":"2017-09-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on September 22, 2017. This option vests in three equal annual installments over a three-year period from the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":1.12,"expiration_date":"2027-09-21","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001600132-17-000102","document":"wf-form4_150645953894625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000160013217000102/wf-form4_150645953894625.xml","form_type":"4"}},{"id":4268954,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-30T22:43:25.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":25363,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":170617,"source":{"system":"sec-edgar","filing":"0001600132-17-000065","document":"wf-form4_149886259042818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000160013217000065/wf-form4_149886259042818.xml","form_type":"4"}},{"id":4302612,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42317,"kind":"person","name":"Tasse Daniel","position":1,"cik":"0001502785","reported_name":"Tasse Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T21:02:56.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 24, 2017."}],"balance_after":12500,"derivative":{"exercise_price":18.85,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-17-014577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1502785/000089924317014577/doc4.xml","form_type":"4"}}]}